Le Lézard
Classified in: Health
Subjects: RCL, PSF, CFG

Advisory - Unauthorized sex enhancement product Kangaroo Ultra 3000 seized from The Passion Vault in Edmonton, AB


OTTAWA, ON, April 19, 2022 /CNW/ - Health Canada is advising Canadians that the following product(s) may pose serious health risks. For more information, including what Canadians should do, visit the online safety alert.

Health Canada maintains a list of unauthorized health products that may pose serious health risks so that Canadians can easily identify those they may have purchased and take appropriate action. Canadians are encouraged to check back regularly for updates.

Unauthorized health products

Product &

Promoted Use

Hazard Identified

Company

Action Taken

Kangaroo Ultra 3000 

Sexual enhancement

Product tested by Health Canada and found to contain sildenafil

The Passion Vault

15239 111 Ave NW

Edmonton, AB

Seized from the retail location

 

Images

For photos of this product, please visit the online safety alert.

Stay connected with Health Canada and receive the latest advisories and product recalls.

Également disponible en français

SOURCE Health Canada


These press releases may also interest you

at 19:20
Whitman-Walker Institute Decries Misleading Propaganda About Transgender Health During Congressional Hearing
Whitman-Walker Institute, which leverages research, policy, and education to advance health equity nationwide, says it's standing by to further inform the chair of the U.S. House Committee on Education and the Workforce and others about the strong...

at 18:50
AKRO Investors: Reminder - Important Deadline in Securities Fraud Class Action Lawsuit Akero Therapeutics, Inc.
The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Northern District of California against Akero Therapeutics, Inc....

at 18:46
FDA APPROVES IMDELLTRAtm (TARLATAMAB-DLLE), THE FIRST AND ONLY T-CELL ENGAGER THERAPY FOR THE TREATMENT OF EXTENSIVE-STAGE SMALL CELL LUNG CANCER
Amgen today announced that the U.S. Food and Drug Administration (FDA) has approved IMDELLTRAtm (tarlatamab-dlle) for the...

at 18:42
Join Housecall Providers at Toss for a Cause: A Free, Community-wide Event Spotlighting Nonprofit Innovation in Elder and Disability Care
Housecall Providers, a nonprofit home-based medical organization invites the community to Sellwood Park, Saturday, June 1, from noon ? 4:00 p.m. for an inspiring afternoon of learning, connection and some friendly competition. Toss...

at 18:30
BioSyent Releases Financial Results for Q1 2024
BioSyent Inc. ("BioSyent", TSX Venture: RX) released today its financial results for the three months (Q1) ended March 31, 2024. Key highlights include:  (CAD)Q1 2024% Change vs.Q1 2023Trailing Twelve Months(TTM) March 31, 2024% Change vs.TTMMarch...

at 18:30
IntraCare Marks Major Milestone: Significant Partnership Finalized with Arizona's Multi-Clinic Cornerstone Family Medicine
IntraCare, a prominent Texas-based MSO, recently signed a partnership agreement with one of Arizona's largest and leading healthcare providers, Cornerstone Family Medicine, which operates...

More news about Health...


News published on and distributed by: